First Trust NYSE Arca Biotechnology Index Fund
199 hedge funds and large institutions have $677M invested in First Trust NYSE Arca Biotechnology Index Fund in 2020 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 61 increasing their positions, 64 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% less funds holding
Funds holding: 210 → 199 (-11)
17% less capital invested
Capital invested by funds: $818M → $677M (-$141M)
20% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 35
Holders
199
Holding in Top 10
5
Calls
$1.35M
Puts
$302K
Top Buyers
| 1 | +$13.3M | |
| 2 | +$4.64M | |
| 3 | +$4.49M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.89M |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$2.35M |
Top Sellers
| 1 | -$20.4M | |
| 2 | -$16.8M | |
| 3 | -$15.5M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$9.56M |
| 5 |
HSBC Holdings
London,
United Kingdom
|
-$4.79M |